FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/01/079657 [Registered on: 28/01/2025] Trial Registered Prospectively
Last Modified On: 23/01/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Study to compare radiofrequency ablation and trichloroacetic acid (TCA) 50% chemical in xanthelasma patients. 
Scientific Title of Study   A comparative study of radiofrequency ablation(RFA) with wound suturing versus trichloroacetic acid (TCA) 50% in the treatment of xanthelasma palpebrum. 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ketki 
Designation  Assistant Professor 
Affiliation  eras lucknow medical college and hospital 
Address  Department of Dermatology, Eras Lucknow Medical College and Hospital, Sarfaraz Ganj Lucknow

Lucknow
UTTAR PRADESH
226003
India 
Phone  9873701332  
Fax    
Email  ketkilhmc@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Ketki 
Designation  Assistant Professor 
Affiliation  eras lucknow medical college and hospital 
Address  Department of Dermatology, Eras Lucknow Medical College and Hospital, Sarfaraz Ganj Lucknow
Department of Dermatology, Eras Lucknow Medical College and Hospital, Sarfaraz Ganj Lucknow
Lucknow
UTTAR PRADESH
226003
India 
Phone  9873701332  
Fax    
Email  ketkilhmc@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Ketki 
Designation  Assistant Professor 
Affiliation  eras lucknow medical college and hospital 
Address  Department of Dermatology, Eras Lucknow Medical College and Hospital, Sarfaraz Ganj Lucknow

Lucknow
UTTAR PRADESH
226003
India 
Phone  9873701332  
Fax    
Email  ketkilhmc@gmail.com  
 
Source of Monetary or Material Support  
Eras Lucknow Medical College and Hospital , Lucknow, Uttar Pradesh India 226003 
 
Primary Sponsor  
Name  Eras Lucknow Medical College and Hospital Lucknow 
Address  Department of Dermatology, Eras Lucknow Medical College and Hospital, Sarfaraz Ganj Lucknow Uttar Pradesh India 226003 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
nil  nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ketki  Eras Lucknow Medical College and Hospital  Second floor, Department of Dermatology, Eras Lucknow Medical College and Hospital, Sarfaraz Ganj Lucknow Uttar pradesh
Lucknow
UTTAR PRADESH 
9873701332

ketkilhmc@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Eras Lucknow Medical College and Hospital , Lucknow  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L989||Disorder of the skin and subcutaneous tissue, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Radiofrequency ablation  radiofrequency ablation followed by suturing Frequency- once Route - radiofrequency ablation over the lesions Follow up- 2 weeks, 4 weeks and 6 weeks Duration of study - 6 weeks After completion of trial period, treatment of the patient with the drug shall continue if necessary. 
Intervention  Trichloroacetic acid (50%)  trichloroacetic acid Dose-50% Frequency- once in two weeks Route - Topical application over the lesions Follow up- 2 weeks, 4 weeks and 6 weeks Duration of study - 6 weeks After completion of trial period, treatment of the patient with the drug shall continue if necessary. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Patients with clinical diagnosis of Xanthelasma palpebrum presenting in the Dermatology OPD of Eras Lucknow Medical College. 
 
ExclusionCriteria 
Details  1) any active eyelid infection, eyelid eczema, keloidal tendency, patients with pacemaker, allergy to lidocaine, pregnant and lactating 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To compare the efficacy of Radiofrequency ablation (RFA) with wound suturing versus Trichloroacetic acid (TCA) 50% in the treatment of xanthelasma palpebrum  0, 2, 4, 6 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
To study and compare the side effects of Radiofrequency ablation (RFA) with wound suturing versus Trichloroacetic acid (TCA) 50% in the treatment of xanthelasma palpebrum  0, 2, 4, 6 weeks 
 
Target Sample Size   Total Sample Size="46"
Sample Size from India="46" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
A total of 46 patients presenting to the Department of Dermatology, Eras Lucknow Medical College and Hospital, Lucknow with clinical diagnosis of xanthelasma palpebrum will be approached for participation in the study. Patients meeting the inclusion and exclusion criteria and giving written consent for participating in the study shall be recruited. History and clinical examination with photographic documentation will be done before starting treatment and then at each visit. Patients will be randomly divided into two groups – A and B each containing 23 individuals. In group A – Patients will be advised to apply Trichloroacetic acid (50%) once in 2 weeks over the lesion for 6 weeks. In group B – Patients will be advised for radiofrequency ablation of the lesion followed by wound suturing. sutures will be removed after 1 week. Results will be noted at each follow up at 2, 4 and 6 weeks and at each follow-up visit clinical response will be determined based on reduction in size as Mild improvement(<25% clearance),Moderate improvement(25-50% clearance),Good improvement(50-75% clearance) and Excellent improvement(>75% clearance). Final outcome will be noted at the end of 6th week. Side effects will be noted at each visit. 
 
Close